Stay updated on FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial

Sign up to get notified when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.
    Difference
    0.3%
    Check dated 2025-07-26T12:11:35.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated to include new content on 'Antibodies, Monoclonal', 'Physiological Effects of Drugs', and 'Immunologic Factors', while the revision number has been updated from v2.16.5 to v2.16.6.
    Difference
    0.7%
    Check dated 2025-07-19T10:49:11.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page now includes a service alert about planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours. Additionally, the version has been updated from v2.16.4 to v2.16.5.
    Difference
    4%
    Check dated 2025-07-12T02:46:47.000Z thumbnail image
  4. Check
    33 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    2%
    Check dated 2025-06-20T17:58:17.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T15:47:50.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The web page has undergone a version update from v2.16.1 to v2.16.2, with several key topics related to antibodies, physiological effects of drugs, and immunologic factors removed.
    Difference
    0.7%
    Check dated 2025-06-06T09:30:33.000Z thumbnail image

Stay in the know with updates to FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.